Anti-BRD2 Antibody (pSer37)__Rabbit Anti-Human BRD2 (pSer37) Polyclonal Itacitinib
BRD 7389
BRD 7389__p90 RSK kinase inhibitor Exendin-4
Product Name
BRD 7389
Description
p90 RSK kinase inhibitor
Purity
>98% (HPLC)
CAS No.
376382-11-5
Molecular Formula
C24H18N2O2
Molecular Weight
366.4
Storage Temperature
-20ºC
Shipping Temperature
Shipped Ambient
Product Type
Inhibitor
Solubility
Soluble to 100 mM in DMSO
Source
Synthetic
Appearance
Orange powder
SMILES
C1=CC=C(C=C1)CCNC2=C3C4=CC=CC=C4C(=O)C5=C3C(=CC=C5)NC2=O
InChI
InChI=1S/C24H18N2O2/c27-23-17-10-5-4-9-16(17)21-20-18(23)11-6-12-19(20)26-24(28)22(21)25-14-13-15-7-2-1-3-8-15/h1-12,20,25H,13-14H2
InChIKey
QVEVXIXBUORVGE-UHFFFAOYSA-N
Safety Phrases
Classification:
Not a hazardous substance or mixture.
Safety Phrases:
S22 – Do not breathe dust.
S24/25 – Avoid contact with skin and eyes.
S36/37/39 – Wear suitable protective clothing, gloves and eye/face protection.
Cite This Product
BRD 7389 (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-497)
References PubMed ID::http://www.ncbi.nlm.nih.gov/pubmed/19116683
Alternative Names
BRD7389, BRD-7389, 1-(2-Phenylethyl)amino-3H-naphtho1,2,3-dequinoline-2,7-dione, 1-Phenethylamino-3H-naphtho1,2,3-dequinoline-2,7-dione
Research Areas
Cancer, Apoptosis, Cancer Growth Inhibitors, Cell Signaling, Tyrosine Kinase Inhibitors
PubChem ID
24870634
Scientific Background
BRD 7389 is a p90 ribosomal S6 kinase (RSK) inhibitor. Specifically, BRD7398 inhibits RSK1, RSK2 and RSK3. This compound has been seen to unregulate insulin expression in terminally differentiated pancreatic &alpha-cells.
References
1. Fomina-Yadlin D., et al. (2010) Pro. Nat. Acad.Sci. USA. 107(34): 15099–15104.
p90 RSK kinase inhibitor
Not a hazardous substance or mixture.
Safety Phrases:
S22 – Do not breathe dust.
S24/25 – Avoid contact with skin and eyes.
S36/37/39 – Wear suitable protective clothing, gloves and eye/face protection.
Anti-BRAF Antibody
Anti-BRAF Antibody__Rabbit Anti-Human BRAF Polyclonal Cabozantinib
Storage Buffer
PBS pH7.4, 50% glycerol, 0.025% Thimerosal
Storage Temperature
-20ºC
Shipping Temperature
Blue Ice or 4ºC
Purification
Peptide Affinity Purified
Clonality
Polyclonal
Specificity
Detects 84.491 kDa.
Cite This Product
Rabbit Anti-Human BRAF Polyclonal (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SPC-1110)
Certificate of Analysis
A 1:250 dilution of SPC-1110 was sufficient for detection of BRAF in 10 µg of human liver lysate by ECL immunoblot analysis using goat anti-rabbit IgG:HRP as the secondary antibody.
References PubMed ID::http://www.ncbi.nlm.nih.gov/pubmed/19116680
Alternative Names
94 kDa B raf protein antibody, B raf 1 antibody, B Raf proto oncogene serine threonine protein kinase antibody, B RAF1 antibody, B-Raf proto-oncogene serine/threonine-protein kinase (p94) antibody, BRAF 1 antibody, BRAF antibody, BRAF_HUMAN antibody, BRAF1 antibody, Murine sarcoma viral (v-raf) oncogene homolog B1 antibody, NS7 antibody, p94 antibody, Proto-oncogene B-Raf antibody, Proto-oncogene c-Rmil antibody, RAFB 1 antibody, RAFB1 antibody, RMIL antibody, Serine/threonine-protein kinase B-raf antibody, v raf murine sarcoma viral oncogene homolog B antibody
Cellular Localization
Cytoplasm, Cell membrane, Nucleus
Accession Number
NP_004324
Gene ID
673
Swiss Prot
P15056
Scientific Background
BRAF is a serine/threonine kinase that participates in the RAS>RAF>MEK>ERK/MAPK pathway, which is involved in the transduction of mitogenic signals from the cell membrane to the nucleus. Ras isoforms are inactive when bound to GDP, but when they are bound to GTP they become active and promote phosphorylation and activation of B-Raf. BRAF is expressed in most tissues with high expression in neuronal tissue. Several genes have been found to be activated by this pathway, among them, cyclins D1, D2 and D3, VEGF, c-myc, b3-integrin and mdm2. BRAF is frequently mutated in human cancers (e.g. sarcomas, colorectal adenocarcinomas, metastatic melanomas, ovarian serous carcinomas, pilocytic astrocytomas); out of 153,189 human tumours, 20.2% featured RafB mutations primarily with the V600E substitutions. This mutation results in constitutive and elevated kinase catalytic activity.
Bortezomib
Bortezomib__Proteasome inhibitor Erdafitinib
Product Name
Bortezomib
Description
Proteasome inhibitor
Purity
>98%
CAS No.
179324-69-7
Molecular Formula
C19H25BN4O4
Molecular Weight
384.2
Storage Temperature
-20ºC
Shipping Temperature
Shipped Ambient
Product Type
Inhibitor
Solubility
Soluble in 50 mg/ml DMSO, 35 mg/ml Ethanol
Source
Synthetic
Appearance
White Powder
SMILES
B(email protected(CC(C)C)NC(=O)email protected(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
InChI
InChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17-/m0/s1
InChIKey
GXJABQQUPOEUTA-RDJZCZTQSA-N
Safety Phrases
Classification: Caution: Substance not yet fully tested.
Safety Phrases:
S22 – Do not breathe dust
S36/37/39 – Wear suitable protective clothing, gloves and eye/face protection
S24/25- Avoid contact with skin and eyes
Cite This Product
Bortezomib (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-328)
References PubMed ID::http://www.ncbi.nlm.nih.gov/pubmed/19116677
Alternative Names
B-(1R)-3-Methyl-1-(2S)-1-oxo-3-phenyl-2-(2-pyrazinylcarbonyl)aminopropylaminobutylboronic Acid; (1R)-3-Methyl-1-(2S)-1-oxo-3-phenyl-2-(pyrazinylcarbonyl)aminopropylaminobutylboronic Acid; Velcade; Radiciol; NSC 681239; DPBA; LDP 341; MG 341; mlN 341; NSC 681239; PS 314; PS 341; Radiciol; Velcade
Research Areas
Cancer, Apoptosis, Cancer Growth Inhibitors, Proteasome Inhibitors
PubChem ID
387447
Scientific Background
Potent and selective proteasome inhibitor (Ki=0.6 nM). Inhibits proliferation of a number of tumor cell lines (IC50=7 nM). Inhibits TNF synthesis and FGF-induced angiogenesis. Reversible. Cell permeable.
References
1. Adams J., et al. (1999) Cancer Res. 59: 2615.
2. Williams S., et al. (2003) Mol. Cancer Ther. 2: 835.
Proteasome inhibitor
Safety Phrases:
S22 – Do not breathe dust
S36/37/39 – Wear suitable protective clothing, gloves and eye/face protection
S24/25- Avoid contact with skin and eyes
2. Williams S., et al. (2003) Mol. Cancer Ther. 2: 835.
Borrelidin
Borrelidin__Angiogenesis inhibitor AdipoRon
Product Name
Borrelidin
Description
Angiogenesis inhibitor
Purity
>98% (HPLC); NMR (conforms)
CAS No.
7184-60-3
Molecular Formula
C28H43NO6
Molecular Weight
489.7
Storage Temperature
-20ºC
Shipping Temperature
Blue Ice or 4ºC
Product Type
Inhibitor
Solubility
May be dissolved in DMSO or ethanol
Source
Fermentation from Streptomyces sp
Appearance
White crystalline powder
SMILES
CC1CC(C)CC(C)C(O)/C(=C/C=C/CC(OC(=O)CC(O)C(C)C1)C2CCCC2C(O)=O)C#N
InChI
InChI=1S/C28H43NO6/c1-17-12-18(2)14-20(4)27(32)21(16-29)8-5-6-11-25(22-9-7-10-23(22)28(33)34)35-26(31)15-24(30)19(3)13-17/h5-6,8,17-20,22-25,27,30,32H,7,9-15H2,1-4H3,(H,33,34)/b6-5+,21-8+
InChIKey
InChIKey=OJCKRNPLOZHAOU-SLNPHPKOSA-N
Safety Phrases
WHMIS Classification:
Not WHMIS controlled. Not a dangerous substance according to GHS.
HMIS Classification:
Health hazard: 0
Flammability: 0
Physical hazards: 0
Potential Health Effects:
Inhalation – May be harmful if inhaled. May cause respiratory tract irritation.
Skin – May be harmful if absorbed through skin. May cause skin irritation.
Eyes – May cause eye irritation.
Ingestion – May be harmful if swallowed.
Cite This Product
Borrelidin (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-546)
References PubMed ID::http://www.ncbi.nlm.nih.gov/pubmed/19116673
Alternative Names
2-(4E,6E)-7-cyano-8,16-dihydroxy-9,11,13,15-tetramethyl-18-oxo-1-oxacyclooctadeca-4,6-dien-2-ylcyclopentane-1-carboxylic acid, 2-(4E,6E)-7-cyano-8,16-dihydroxy-9,11,13,15-tetramethyl-18-oxo-1-oxacyclooctadeca-4,6-dien-2-yl-1-cyclopentanecarboxylic acid
2-(4E,6E)-7-cyano-8,16-dihydroxy-18-keto-9,11,13,15-tetramethyl-1-oxacyclooctadeca-4,6-dien-2-ylcyclopentane-1-carboxylic acid, 7184-60-3, BORRELIDIN, Cyclopentanecarboxylic acid, 2-(7-cyano-8,16-dihydroxy-9,11,13,15-tetramethyl-18-oxooxacyclooctadeca-4,6-dien-2-yl)-, Cyclopentanecarboxylic acid, 2-(2S,4E,6Z,8R,9S,11R,13S,15S, 16S)-7-cyano-8,16-dihydroxy-9,11,13,15-tetramethyl-18-oxooxacyclooctadeca-4,6-dien-2-yl-, (1R,2R)-, NSC216128, Cyclopentanecarboxylic acid, 2-(7-cyano-8,16-dihydroxy-9,11, Cyclopentanecarboxylic acid, 2-(2S,4E,6Z,8R,9S,11R,13S,15S, 16S)-7-cyano-8,16-dihydroxy-9,11,13,15-tetramethyl-18-oxooxacyclooctadeca-4,6-dien-2-yl-, (1R,2R)-, NSC271295, NSC277295, 2-(4E,6E)-7-cyano-8,16-dihydroxy-9,11,13,15-tetramethyl-18-oxo-1-oxacyclooctadeca-4,6-dien-2-ylcyclopentane-1-carboxylic acid, Treponemycin
Research Areas
Cancer, Angiogenesis, Apoptosis, Cardiovascular System, Cell Signaling
PubChem ID
6436801
Angiogenesis inhibitor
Not WHMIS controlled. Not a dangerous substance according to GHS.
HMIS Classification:
Health hazard: 0
Flammability: 0
Physical hazards: 0
Potential Health Effects:
Inhalation – May be harmful if inhaled. May cause respiratory tract irritation.
Skin – May be harmful if absorbed through skin. May cause skin irritation.
Eyes – May cause eye irritation.
Ingestion – May be harmful if swallowed.
2-(4E,6E)-7-cyano-8,16-dihydroxy-18-keto-9,11,13,15-tetramethyl-1-oxacyclooctadeca-4,6-dien-2-ylcyclopentane-1-carboxylic acid, 7184-60-3, BORRELIDIN, Cyclopentanecarboxylic acid, 2-(7-cyano-8,16-dihydroxy-9,11,13,15-tetramethyl-18-oxooxacyclooctadeca-4,6-dien-2-yl)-, Cyclopentanecarboxylic acid, 2-(2S,4E,6Z,8R,9S,11R,13S,15S, 16S)-7-cyano-8,16-dihydroxy-9,11,13,15-tetramethyl-18-oxooxacyclooctadeca-4,6-dien-2-yl-, (1R,2R)-, NSC216128, Cyclopentanecarboxylic acid, 2-(7-cyano-8,16-dihydroxy-9,11, Cyclopentanecarboxylic acid, 2-(2S,4E,6Z,8R,9S,11R,13S,15S, 16S)-7-cyano-8,16-dihydroxy-9,11,13,15-tetramethyl-18-oxooxacyclooctadeca-4,6-dien-2-yl-, (1R,2R)-, NSC271295, NSC277295, 2-(4E,6E)-7-cyano-8,16-dihydroxy-9,11,13,15-tetramethyl-18-oxo-1-oxacyclooctadeca-4,6-dien-2-ylcyclopentane-1-carboxylic acid, Treponemycin
Anti-BNIP3 Antibody
Anti-BNIP3 Antibody__Rabbit Anti-Human BNIP3 Polyclonal GDC-0853
Product Name
BNIP3 Antibody
Description
Rabbit Anti-Human BNIP3 Polyclonal
Species Reactivity
Human, Mouse
Applications
,
WB
,
ICC/IF
Antibody Dilution
WB (1:1000); ICC/IF (1:100); optimal dilutions for assays should be determined by the user.
Host Species
Rabbit
Immunogen Species
Human
Immunogen
Synthetic peptide from the C-terminal of human BNIP3
Concentration
1 mg/ml
Conjugates
Alkaline Phosphatase, APC, ATTO 390, ATTO 488, ATTO 565, ATTO 594, ATTO 633, ATTO 655, ATTO 680, ATTO 700, Biotin, FITC, HRP, PE/ATTO 594, PerCP, RPE, Streptavidin, Unconjugated
APC (Allophycocyanin)
Overview:
- High quantum yield
- Large phycobiliprotein
- 6 chromophores per molecule
- Isolated from red algae
- Molecular Weight: 105 kDa

Optical Properties:
λex = 650 nm
λem = 660 nm
εmax = 7.0×105
Φf = 0.68
Brightness = 476
Laser = 594 or 633 nm
Filter set = Cy®5
ATTO 390
Overview:
- High fluorescence yield
- Large Stokes-shift (89 nm)
- Good photostability
- Moderately hydrophilic
- Good solubility in polar solvents
- Coumarin derivate, uncharged
- Low molar mass: 343.42 g/mol
ATTO 390 Datasheet

Optical Properties:
λex = 390 nm
λem = 479 nm
εmax = 2.4×104
Φf = 0.90
τfl = 5.0 ns
Brightness = 21.6
Laser = 365 or 405 nm
ATTO 488
Overview:

Optical Properties:
λex = 501 nm
λem = 523 nm
εmax = 9.0×104
Φf = 0.80
τfl = 4.1 ns
Brightness = 72
Laser = 488 nm
Filter set = FITC
ATTO 565
Overview:

Optical Properties:
λex = 563 nm
λem = 592 nm
εmax = 1.2×105
Φf = 0.9
τfl = 3.4 n
Brightness = 10
Laser = 532 nm
Filter set = TRITC
ATTO 594
Overview:

Optical Properties:
λex = 601 nm
λem = 627 nm
εmax = 1.2×105
Φf = 0.85
τfl = 3.5 ns
Brightness = 102
Laser = 594 nm
Filter set = Texas Red®
ATTO 633
Overview:

Optical Properties:
λex = 629 nm
λem = 657 nm
εmax = 1.3×105
Φf = 0.64
τfl = 3.2 ns
Brightness = 83.2
Laser = 633 nm
Filter set = Cy®5
ATTO 655
Overview:

Optical Properties:
λex = 663 nm
λem = 684 nm
εmax = 1.25×105
Φf = 0.30
τfl = 1.8 ns
Brightness = 37.5
Laser = 633 – 647 nm
Filter set = Cy®5
ATTO 680
Overview:

Optical Properties:
λex = 680 nm
λem = 700 nm
εmax = 1.25×105
Φf = 0.30
τfl = 1.7 ns
Brightness = 37.5
Laser = 633 – 676 nm
Filter set = Cy®5.5
ATTO 700
Overview:
- High fluorescence yield
- Excellent thermal and photostability
- Quenched by electron donors
- Very hydrophilic
- Good solubility in polar solvents
- Zwitterionic dye
- Molar Mass: 575 g/mol

Optical Properties:
λex = 700 nm
λem = 719 nm
εmax = 1.25×105
Φf = 0.25
τfl = 1.6 ns
Brightness = 31.3
Laser = 676 nm
Filter set = Cy®5.5
FITC (Fluorescein)
Overview:

Optical Properties:
λex = 494 nm
λem = 520 nm
εmax = 7.3×104
Φf = 0.92
τfl = 5.0 ns
Brightness = 67.2
Laser = 488 nm
Filter set = FITC
PE/ATTO 594
PE/ATTO 594 is a tandem conjugate, where PE is excited at 535 nm and transfers energy to ATTO 594 via FRET (fluorescence resonance energy transfer), which emits at 627 nm.
Overview:

Optical Properties:
λex = 535 nm
λem = 627 nm
Laser = 488 to 561 nm
PerCP
Overview:

Optical Properties:
λex = 482 nm
λem = 677 nm
εmax = 1.96 x 106
Laser = 488 nm
R-PE (R-Phycoerythrin)
Overview:

Optical Properties:
λex = 565 nm
λem = 575 nm
εmax = 2.0×106
Φf = 0.84
Brightness = 1.68 x 103
Laser = 488 to 561 nm
Filter set = TRITC
AP (Alkaline Phosphatase)
Properties:
- Broad enzymatic activity for phosphate esters of alcohols, amines, pyrophosphate, and phenols
- Commonly used to dephosphorylate the 5’-termini of DNA and RNA to prevent self-ligation
- Catalyzes the conversion of:
- Chromogenic substrates (e.g. pNPP, naphthol AS-TR phosphate, BCIP) into coloured products
- Fluorogenic substrates (e.g. 4-methylumbelliferyl phosphate) into fluorescent products
- Molecular weight: 140 kDa
- Applications: Western blot, immunohistochemistry, and ELISA
HRP (Horseradish peroxidase)
Properties:
- Enzymatic activity is used to amplify weak signals and increase visibility of a target
- Readily combines with hydrogen peroxide (H2O2) to form HRP-H2O2 complex which can oxidize various hydrogen donors
- Catalyzes the conversion of:
- Chromogenic substrates (e.g. TMB, DAB, ABTS) into coloured products
- Chemiluminescent substrates (e.g. luminol and isoluminol) into light emitting products via enhanced chemiluminescence (ECL)
- Fluorogenic substrates (e.g. tyramine, homovanillic acid, and 4-hydroxyphenyl acetic acid) into fluorescent products
- High turnover rate enables rapid generation of a strong signal
- 44 kDa glycoprotein
- Extinction coefficient: 100 (403 nm)
- Applications: Western blot, immunohistochemistry, and ELISA
Biotin
Properties:
Streptavidin
Properties:
- Homo-tetrameric protein purified from Streptomyces avidinii which binds four biotin molecules with extremely high affinity
- Molecular weight: 53 kDa
- Formula: C10H16N2O3S
- Applications: Western blot, immunohistochemistry, and ELISA
Storage Buffer
PBS, 50% glycerol, 0.09% sodium azide
Storage Temperature
-20ºC
Shipping Temperature
Blue Ice or 4ºC
Purification
Peptide Affinity Purified
Clonality
Polyclonal
Specificity
Predicted molecular weight at ~21.5kDa. Observed bands at ~20-30kDa and 50-60kDa due to the homodimer complex of BNIP3.
Cite This Product
Rabbit Anti-Human BNIP3 Polyclonal (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SPC-685)
Certificate of Analysis
A 1:1000 dilution of SPC-685 was sufficient for detection of BNIP3 on mouse kidney lysates using Goat anti-rabbit IgG:HRP as the secondary antibody.
References PubMed ID::http://www.ncbi.nlm.nih.gov/pubmed/19116653
Alternative Names
NIP3 Antibody, BCL2 Adenovirus E1B 19kDa Interacting Protein 3 Antibody, BNIP3_Human Antibody
Research Areas
Cancer, Apoptosis, Cardiovascular System, Heart
Cellular Localization
Mitochondrion, Mitochondrion outer membrane
Accession Number
NP_004043.3
Gene ID
664
Swiss Prot
Q12983
Scientific Background
BNIP3 is an apoptosis-inducing protein which can overcome BCL2 suppression. It may play a role in repartioning calcium between the two major intracellular calcium stores in association with BCL2. It has been shown to interact with CD47, BCL2-like, and BCL-2 (1-3).
References
1. Boyd J.M., et al. (1994) Cell. 79(2): 341-351.
2. Lamy L., et al. (2003) J Biol Chem. 278(26): 23915-23921.
3. Ray R., et al. (2000) J Biol Chem. 275(2): 1439-1448.
Rabbit Anti-Human BNIP3 Polyclonal
WB
,
ICC/IF
APC (Allophycocyanin) | ||
Overview:
|
![]() |
Optical Properties:
λex = 650 nm λem = 660 nm εmax = 7.0×105 Φf = 0.68 Brightness = 476 Laser = 594 or 633 nm Filter set = Cy®5 |
ATTO 390 | ||
Overview:
ATTO 390 Datasheet |
![]() |
Optical Properties:
λex = 390 nm λem = 479 nm εmax = 2.4×104 Φf = 0.90 τfl = 5.0 ns Brightness = 21.6 Laser = 365 or 405 nm |
ATTO 488 | ||
Overview: | ![]() |
Optical Properties:
λex = 501 nm λem = 523 nm εmax = 9.0×104 Φf = 0.80 τfl = 4.1 ns Brightness = 72 Laser = 488 nm Filter set = FITC |
ATTO 565 | ||
Overview: | ![]() |
Optical Properties:
λex = 563 nm λem = 592 nm εmax = 1.2×105 Φf = 0.9 τfl = 3.4 n Brightness = 10 Laser = 532 nm Filter set = TRITC |
ATTO 594 | ||
Overview: | ![]() |
Optical Properties:
λex = 601 nm λem = 627 nm εmax = 1.2×105 Φf = 0.85 τfl = 3.5 ns Brightness = 102 Laser = 594 nm Filter set = Texas Red® |
ATTO 633 | ||
Overview: | ![]() |
Optical Properties:
λex = 629 nm λem = 657 nm εmax = 1.3×105 Φf = 0.64 τfl = 3.2 ns Brightness = 83.2 Laser = 633 nm Filter set = Cy®5 |
ATTO 655 | ||
Overview: | ![]() |
Optical Properties:
λex = 663 nm λem = 684 nm εmax = 1.25×105 Φf = 0.30 τfl = 1.8 ns Brightness = 37.5 Laser = 633 – 647 nm Filter set = Cy®5 |
ATTO 680 | ||
Overview: | ![]() |
Optical Properties:
λex = 680 nm λem = 700 nm εmax = 1.25×105 Φf = 0.30 τfl = 1.7 ns Brightness = 37.5 Laser = 633 – 676 nm Filter set = Cy®5.5 |
ATTO 700 | ||
Overview:
|
![]() |
Optical Properties:
λex = 700 nm λem = 719 nm εmax = 1.25×105 Φf = 0.25 τfl = 1.6 ns Brightness = 31.3 Laser = 676 nm Filter set = Cy®5.5 |
FITC (Fluorescein) | ||
Overview: | ![]() |
Optical Properties:
λex = 494 nm λem = 520 nm εmax = 7.3×104 Φf = 0.92 τfl = 5.0 ns Brightness = 67.2 Laser = 488 nm Filter set = FITC |
PE/ATTO 594 | ||
PE/ATTO 594 is a tandem conjugate, where PE is excited at 535 nm and transfers energy to ATTO 594 via FRET (fluorescence resonance energy transfer), which emits at 627 nm. | ||
Overview: | ![]() |
Optical Properties:
λex = 535 nm λem = 627 nm Laser = 488 to 561 nm |
PerCP | ||
Overview: | ![]() |
Optical Properties:
λex = 482 nm λem = 677 nm εmax = 1.96 x 106 Laser = 488 nm |
R-PE (R-Phycoerythrin) | ||
Overview: | ![]() |
Optical Properties:
λex = 565 nm λem = 575 nm εmax = 2.0×106 Φf = 0.84 Brightness = 1.68 x 103 Laser = 488 to 561 nm Filter set = TRITC |
AP (Alkaline Phosphatase)
Properties:
- Broad enzymatic activity for phosphate esters of alcohols, amines, pyrophosphate, and phenols
- Commonly used to dephosphorylate the 5’-termini of DNA and RNA to prevent self-ligation
- Catalyzes the conversion of:
- Chromogenic substrates (e.g. pNPP, naphthol AS-TR phosphate, BCIP) into coloured products
- Fluorogenic substrates (e.g. 4-methylumbelliferyl phosphate) into fluorescent products
- Molecular weight: 140 kDa
- Applications: Western blot, immunohistochemistry, and ELISA
HRP (Horseradish peroxidase)
Properties:
- Enzymatic activity is used to amplify weak signals and increase visibility of a target
- Readily combines with hydrogen peroxide (H2O2) to form HRP-H2O2 complex which can oxidize various hydrogen donors
- Catalyzes the conversion of:
- Chromogenic substrates (e.g. TMB, DAB, ABTS) into coloured products
- Chemiluminescent substrates (e.g. luminol and isoluminol) into light emitting products via enhanced chemiluminescence (ECL)
- Fluorogenic substrates (e.g. tyramine, homovanillic acid, and 4-hydroxyphenyl acetic acid) into fluorescent products
- High turnover rate enables rapid generation of a strong signal
- 44 kDa glycoprotein
- Extinction coefficient: 100 (403 nm)
- Applications: Western blot, immunohistochemistry, and ELISA
Biotin
Properties:
Streptavidin
Properties:
- Homo-tetrameric protein purified from Streptomyces avidinii which binds four biotin molecules with extremely high affinity
- Molecular weight: 53 kDa
- Formula: C10H16N2O3S
- Applications: Western blot, immunohistochemistry, and ELISA
2. Lamy L., et al. (2003) J Biol Chem. 278(26): 23915-23921.
3. Ray R., et al. (2000) J Biol Chem. 275(2): 1439-1448.
BML-278 SIRT1 activator
BML-278 SIRT1 activator__SIRT1 activator PSI-7977
Product Name
BML-278 SIRT1 activator
Description
SIRT1 activator
Purity
>98% (TLC); NMR (Conforms)
Molecular Formula
C24H25NO4
Molecular Weight
391.5
Storage Temperature
-20ºC
Shipping Temperature
Shipped Ambient
Product Type
Inhibitor
Solubility
Soluble in 5 mg/ml DMSO
Source
Synthetic
Appearance
Off-White Solid
Safety Phrases
Classification: Caution – Substance not yet fully tested.
Safety Phrases:
S22 – Do not breathe dust
S36/37/39 – Wear suitable protective clothing, gloves and eye/face protection
S24/25- Avoid contact with skin and eyes
Cite This Product
Bml-278 SIRT1 activator (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-349)
References PubMed ID::http://www.ncbi.nlm.nih.gov/pubmed/19116652
Alternative Names
N-Benzyl-3,5-dicarbethoxy-4-phenyl-1,4-dihydropyridine
Research Areas
Cell Signaling, Epigenetics
Scientific Background
A structurally novel activator of SIRT1 (EC150=1 µM). Displays selectivity over SIRT2 and 3 (EC150=25 and 50 µM respectively). Cell permeable.
References
1. Mai A., et al. (2009) J. Med. Chem. 52: 5496.
SIRT1 activator
Safety Phrases:
S22 – Do not breathe dust
S36/37/39 – Wear suitable protective clothing, gloves and eye/face protection
S24/25- Avoid contact with skin and eyes
BML-210
BML-210__HDAC inhibitor PF-04691502
Product Name
BML-210
Description
HDAC inhibitor
Purity
>98% (TLC); NMR (Conforms)
CAS No.
537034-17-6
Molecular Formula
C20H25N3O2
Molecular Weight
339.4
Storage Temperature
-20ºC
Shipping Temperature
Shipped Ambient
Product Type
Inhibitor
Solubility
Soluble in 25 mg/ml DMSO or 10 mg/ml Ethanol
Source
Synthetic
Appearance
Tan Solid
SMILES
C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NC2=CC=CC=C2N
InChI
InChI=1S/C20H25N3O2/c21-17-12-8-9-13-18(17)23-20(25)15-7-2-1-6-14-19(24)22-16-10-4-3-5-11-16/h3-5,8-13H,1-2,6-7,14-15,21H2,(H,22,24)(H,23,25)
InChIKey
RFLHBLWLFUFFDZ-UHFFFAOYSA-N
Safety Phrases
Classification: Caution- Substance not yet fully tested.
Safety Phrases:
S22 – Do not breathe dust
S36/37/39 – Wear suitable protective clothing, gloves and eye/face protection
S24/25- Avoid contact with skin and eyes
Hazard Statements:
H413 – May cause long lasting harmful effects to aquatic life.
Cite This Product
Bml-210 (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-348)
References PubMed ID::http://www.ncbi.nlm.nih.gov/pubmed/19116637
Alternative Names
N1-(2-aminophenyl)-N8-phenyloctanediamide
Research Areas
Cancer, Cell Signaling, Epigenetics
PubChem ID
9543540
Scientific Background
A novel non-hydroxamic acid HDAC inhibitor. IC50=5-10 µM (HeLa nuclear extract). Induces growth inhibition, proapoptotic and differentiation effects on human leukemia cell lines.
References
1. Savickiene J., et al. (2006) Eur. J. Pharmacol. 549: 9.
2. Herman D., et al. (2006) Nature Chem. Biol. 10: 551.
HDAC inhibitor
Safety Phrases:
S22 – Do not breathe dust
S36/37/39 – Wear suitable protective clothing, gloves and eye/face protection
S24/25- Avoid contact with skin and eyes
Hazard Statements:
H413 – May cause long lasting harmful effects to aquatic life.
2. Herman D., et al. (2006) Nature Chem. Biol. 10: 551.
BML 277
BML 277__CHK2 kinase inhibitor GKT137831
Product Name
BML 277
Description
CHK2 kinase inhibitor
Purity
>98% (TLC)
CAS No.
516480-79-8
Molecular Formula
C20H14ClN3O2
Molecular Weight
363.8
Storage Temperature
-20ºC
Shipping Temperature
Shipped Ambient
Product Type
Inhibitor
Solubility
Soluble in DMSO (20 mg/ml) or ethanol (20 mg/ml)
Source
Synthetic
Appearance
Off-white solid
SMILES
C1=CC(=CC=C1C2=NC3=C(N2)C=CC(=C3)C(=O)N)OC4=CC=C(C=C4)Cl
InChI
InChI=1S/C20H14ClN3O2/c21-14-4-8-16(9-5-14)26-15-6-1-12(2-7-15)20-23-17-10-3-13(19(22)25)11-18(17)24-20/h1-11H,(H2,22,25)(H,23,24)
InChIKey
UXGJAOIJSROTTN-UHFFFAOYSA-N
Safety Phrases
Classification:
Not a hazardous substance or mixture.
Safety Phrases:
S22 – Do not breathe dust.
S24/25 – Avoid contact with skin and eyes.
S36/37/39 – Wear suitable protective clothing, gloves and eye/face protection.
Cite This Product
Bml 277 (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-436)
References PubMed ID::http://www.ncbi.nlm.nih.gov/pubmed/19116604
Alternative Names
Chk2 Inhibitor II, Chk2 Inhibitor II hydrate, 2-(4-(4-Chlorophenoxy)phenyl)-1H-benzimidazole-5-carboxamide hydrate
Research Areas
Cancer, Apoptosis, Cancer Growth Inhibitors, Cell Signaling, Tyrosine Kinase Inhibitors
PubChem ID
9969021
Scientific Background
Bml 277 is a highly selective inhibitor of Chk2, making it a useful tool for dissecting the role of Chk2 in cellular signaling.
References
1. Pereg Y., et al. (2006) Mol. Cell Biol. 26(18): 6819–6831.
CHK2 kinase inhibitor
Not a hazardous substance or mixture.
Safety Phrases:
S22 – Do not breathe dust.
S24/25 – Avoid contact with skin and eyes.
S36/37/39 – Wear suitable protective clothing, gloves and eye/face protection.
BML 259
BML 259__CDK5, p25 kinase inhibitor PF-04447943
Product Name
BML 259
Description
CDK5, p25 kinase inhibitor
Purity
>98% (TLC)
CAS No.
267654-00-2
Molecular Formula
C14H16N2OS
Molecular Weight
260.4
Storage Temperature
-20ºC
Shipping Temperature
Shipped Ambient
Product Type
Inhibitor
Solubility
Soluble in DMSO (30 mg/ml), dimethyl formamide (30 mg/ml) or 100% ethanol (0.25 mg/ml)
Source
Synthetic
Appearance
White solid
SMILES
CC(C)C1=CN=C(S1)NC(=O)CC2=CC=CC=C2
InChI
InChI=1S/C14H16N2OS/c1-10(2)12-9-15-14(18-12)16-13(17)8-11-6-4-3-5-7-11/h3-7,9-10H,8H2,1-2H3,(H,15,16,17)
InChIKey
IGRZXNLKVUEFDM-UHFFFAOYSA-N
Safety Phrases
Classification:
Not a hazardous substance or mixture.
Safety Phrases:
S22 – Do not breathe dust.
S24/25 – Avoid contact with skin and eyes.
S36/37/39 – Wear suitable protective clothing, gloves and eye/face protection.
Cite This Product
Bml 259 (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-435)
References PubMed ID::http://www.ncbi.nlm.nih.gov/pubmed/1911659
Alternative Names
N-(5-Isopropylthiazol-2-yl)phenylacetamide
Research Areas
Cancer, Apoptosis, Cancer Growth Inhibitors, Cell Signaling, Tyrosine Kinase Inhibitors
PubChem ID
16760027
Scientific Background
Bml 259 is a potent inhibitor of Cdk5/p25. It also inhibits Cdk2/cyclin E.
References
1. Kaźmierczak A., Czapski G.A., Adamczyk A., Gajkowska B., & Strosznajder J.B. (2011) Neurochem. Int. 58(2): 206–214.
CDK5, p25 kinase inhibitor
Not a hazardous substance or mixture.
Safety Phrases:
S22 – Do not breathe dust.
S24/25 – Avoid contact with skin and eyes.
S36/37/39 – Wear suitable protective clothing, gloves and eye/face protection.